Author

Akhil Agarwal

Institution: B. Braun (United States)

Observed institutions: GlaxoSmithKline (India), B. Braun (United States), Pfizer (India)

ORCID: 0000-0002-1828-7340

Observed ORCID: 0000-0002-1828-7340

OpenAlex ID: A5068481850

Epidemiology of Medication Errors in Indian Hospital Settings: A Systematic Literature Review

2025 · Deepak Govil, Rashid Ali Khan, et al. · Indian Journal of Critical Care Medicine · 6

Amoxicillin+clavulanic acid in community acquired pneumonia: Past, present, and future from an Indian perspective

2022 · Sandeep Budhiraja, Akhil Agarwal, et al. · Asian Journal of Medical Sciences · 3

Peripherally inserted central catheters versus chemoports for patients with cancer in India: A health-economic evaluation

2025 · Arvind Krishnamurthy, Rashid Ali Khan, et al. · Cancer Research Statistics and Treatment · 1

Indian consensus for the diagnosis and prevention of catheter-related bloodstream infections: A practical, evidence-based framework for a corporate hospital

2026 · Yogendra Pal Singh, Deepak Govil, et al. · Asian Journal of Medical Sciences

Expert Nursing Consensus on Prevention of Intravenous Therapy Complications in Indian Corporate Hospitals

2026 · Usha Banerjee, Juliet Joji, et al. · Apollo Medicine

Financial Impact of CLABSI Prevention on Indian Hospitals: The Hospital Management Perspective

2026 · Pinaki Ghosh, Akhil Agarwal, et al. · Apollo Medicine

Expert opinion survey on medication error awareness, reporting and its challenges among nursing leaders in India

2025 · Shashikala Gonchigar Eswarappa, Akhil Agarwal, et al. · International Journal of Research in Medical Sciences

Study of cerebrospinal fluid adenosine deaminase activity for differential diagnosis of tuberculous and non-tuberculous meningitis

2023 · Seema Agarwal, Santosh Varma, et al. · Asian Journal of Medical Sciences

Works count: 9

Citation count: 9

H-index: 2

I10-index: